Palasan, Charles A.
HRN: 21-59-43 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/20/2022
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
07/20/2022
07/27/2022
IV
1,200mg
Q6
Aspiration Pneumonia
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes